edoc

Items where contributor is "Liechti, Matthias Emanuel"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

2016

Strajhar, Petra and Schmid, Y. and Liakoni, E. and Dolder, P. C. and Rentsch, K. M. and Kratschmar, Denise V. and Odermatt, Alex and Liechti, Matthias E.. (2016) Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects. Journal of neuroendocrinology, 28 (3). p. 12374.

Steuer, Andrea E. and Schmidhauser, Corina and Tingelhoff, Eva H. and Schmid, Yasmin and Rickli, Anna and Kraemer, Thomas and Liechti, Matthias E.. (2016) Impact of cytochrome P450 2D6 function on the chiral blood plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its phase I and II metabolites in humans. PLoS one, 11 (3). e0150955.

Simmler, Linda D. and Buchy, Danièle and Chaboz, Sylvie and Hoener, Marius C. and Liechti, Matthias E.. (2016) In vitro characterization of psychoactive substances at rat, mouse, and human trace amine-associated receptor 1. Journal of pharmacology and experimental therapeutics, 357 (1). pp. 134-144.

Mueller, F. and Lenz, C. and Steiner, M. and Dolder, P. C. and Walter, M. and Lang, U. E. and Liechti, M. E. and Borgwardt, S.. (2016) Neuroimaging in moderate MDMA use: a systematic review. Neuroscience and Biobehavioral Reviews, 62 (8). pp. 21-34.

Madry, Milena M. and Steuer, Andrea E. and Hysek, Cédric M. and Liechti, Matthias E. and Baumgartner, Markus R. and Kraemer, Thomas. (2016) Evaluation of drug incorporation into hair segments and nails by enantiomeric analysis following controlled single MDMA intakes. Analytical and bioanalytical chemistry, 408 (2). pp. 545-556.

Poetzsch, Michael and Steuer, Andrea E. and Hysek, Cédric M. and Liechti, Matthias E. and Kraemer, Thomas. (2016) Development of a high-speed MALDI-triple quadrupole mass spectrometric method for the determination of 3,4-methylenedioxymethamphetamine (MDMA) in oral fluid. Drug testing and analysis, 8 (2). pp. 235-240.

2015

Schmid, Yasmin and Rickli, Anna and Schaffner, Antonia and Duthaler, Urs and Grouzmann, Eric and Hysek, Cédric M. and Liechti, Matthias E.. (2015) Interactions between bupropion and 3,4-methylenedioxymethamphetamine in healthy subjects. Journal of pharmacology and experimental therapeutics, 353 (1). pp. 102-111.

Schmid, Yasmin and Enzler, Florian and Gasser, Peter and Grouzmann, Eric and Preller, Katrin H. and Vollenweider, Franz X. and Brenneisen, Rudolf and Müller, Felix and Borgwardt, Stefan and Liechti, Matthias E.. (2015) Acute effects of lysergic acid diethylamide in healthy subjects. Biological psychiatry, 78 (8). pp. 544-553.

Dolder, Patrick C. and Schmid, Yasmin and Haschke, Manuel and Rentsch, Katharina M. and Liechti, Matthias E.. (2015) Pharmacokinetics and concentration-effect relationship of oral LSD in humans. International journal of neuropsychopharmacology, 19 (1). pyv072.

Schmid, Yasmin and Hysek, Cédric M. and Preller, Katrin H. and Bosch, Oliver G. and Bilderbeck, Amy C. and Rogers, Robert D. and Quednow, Boris B. and Liechti, Matthias E.. (2015) Effects of methylphenidate and MDMA on appraisal of erotic stimuli and intimate relationships. European neuropsychopharmacology, 25 (1). pp. 17-25.

Bigler, Marc B. and Egli, Simon B. and Hysek, Cédric M. and Hoenger, Gideon and Schmied, Laurent and Baldin, Fabian S. and Marquardsen, Florian A. and Recher, Mike and Liechti, Matthias E. and Hess, Christoph and Berger, Christoph T.. (2015) Stress-induced in vivo recruitment of human cytotoxic natural killer cells favors subsets with distinct receptor profiles and associates with increased epinephrine levels. PLoS one, 10 (12). e0145635.

Liakoni, Evangelia and Dolder, Patrick C. and Rentsch, Katharina and Liechti, Matthias E.. (2015) Acute health problems due to recreational drug use in patients presenting to an urban emergency department in Switzerland. Swiss medical weekly, 145. w14166.

Steuer, Andrea E. and Schmidhauser, Corina and Schmid, Yasmin and Rickli, Anna and Liechti, Matthias E. and Kraemer, Thomas. (2015) Chiral plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine and its phase I and II metabolites following controlled administration to humans. Drug metabolism and disposition, 43 (12). pp. 1864-1871.

Steuer, Andrea E. and Schmidhauser, Corina and Liechti, Matthias E. and Kraemer, Thomas. (2015) Development and validation of an LC-MS/MS method after chiral derivatization for the simultaneous stereoselective determination of methylenedioxy-methamphetamine (MDMA) and its phase I and II metabolites in human blood plasma. Drug testing and analysis, 7 (7). pp. 592-602.

Liechti, Matthias E.. (2015) Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signalling. Swiss medical weekly, 145. w14043.

Dolder, Patrick C. and Liechti, Matthias E. and Rentsch, Katharina M.. (2015) Development and validation of a rapid turboflow LC-MS/MS method for the quantification of LSD and 2-oxo-3-hydroxy LSD in serum and urine samples of emergency toxicological cases. Analytical and bioanalytical chemistry, 407 (6). pp. 1577-1584.

2014

Simmler, L. D. and Rickli, A. and Hoener, M. C. and Liechti, M. E.. (2014) Monoamine transporter and receptor interaction profiles of a new series of designer cathinones. Neuropharmacology, Vol. 79. S. 152-160.

Hysek, C. M. and Schmid, Y. and Simmler, L. D. and Domes, G. and Heinrichs, M. and Eisenegger, C. and Preller, K. H. and Quednow, B. B. and Liechti, M. E.. (2014) MDMA enhances emotional empathy and prosocial behavior. Social cognitive and affective neuroscience, 9 (11). pp. 1645-1652.

Hysek, C. M. and Simmler, L. D. and Schillinger, N. and Meyer, N. and Schmid, Y. and Donzelli, M. and Grouzmann, E. and Liechti, M. E.. (2014) Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination. International journal of neuropsychopharmacology, 17 (3). pp. 371-381.

Schmid, Yasmin and Hysek, Cédric M. and Simmler, Linda D. and Crockett, Molly J. and Quednow, Boris B. and Liechti, Matthias E.. (2014) Differential effects of MDMA and methylphenidate on social cognition. Journal of psychopharmacology, 28 (9). pp. 847-856.

Liechti, Matthias E.. (2014) Effects of MDMA on body temperature in humans. Temperature, 1 (3). pp. 179-187.

2013

Maier, L. J. and Liechti, M. E. and Herzig, F. and Schaub, M. P.. (2013) To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students. PLoS one, Vol. 8, H. 11 , e77967.

Hysek, C. M. and Schmid, Y. and Rickli, A. and Liechti, M. E.. (2013) Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans : lost in translation. British journal of pharmacology, 170 (6). pp. 1273-1275.

Hysek, C. M. and Fink, A. E. and Simmler, L. D. and Donzelli, M. and Grouzmann, E. and Liechti, M. E.. (2013) a-Adrenergic receptors contribute to the acute effects of MDMA in humans. Journal of clinical psychopharmacology, Vol. 33, H. 5. S. 658-666.

Maier, L. J. and Liechti, M. E. and Schaub, M.. (2013) Neuroenhancement: auch an Schweizer Universitäten? SuchtMagazin, Jg. 39, H. 3. S. 21-24.

2012

Hysek, C. M. and Simmler, L. D. and Nicola, V. G. and Vischer, N. and Donzelli, M. and Krahenbuhl, S. and Grouzmann, E. and Huwyler, J. and Hoener, M. C. and Liechti, M. E.. (2012) Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study. PLoS one, Vol. 7, H. 5 , e36476.

Simmler, L. D. and Buser, T. A. and Donzelli, M. and Schramm, Y. and Dieu, L. H. and Huwyler, J. and Chaboz, S. and Hoener, M. C. and Liechti, M. E.. (2012) Pharmacological characterization of designer cathinones in vitro. British journal of pharmacology, Vol. 168, no. 2. S. 458-470.

Derungs, A. and Schwaninger, A. E. and Mansella, G. and Bingisser, R. and Kraemer, T. and Liechti, M. E.. (2012) Symptoms, toxicities, and analytical results for a patient after smoking herbs containing the novel synthetic cannabinoid MAM-2201. Forensic toxicology, Vol. 31, H. 1. S. 164-171.

Hysek, C. M. and Brugger, R. and Simmler, L. D. and Bruggisser, M. and Donzelli, M. and Grouzmann, E. and Hoener, M. C. and Liechti, M. E.. (2012) Effects of the α₂-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers. Journal of pharmacology and experimental therapeutics, Vol. 340, H. 2. S. 286-294.

Hysek, C. M. and Domes, G. and Liechti, M. E.. (2012) MDMA enhances "mind reading" of positive emotions and impairs "mind reading" of negative emotions. Psychopharmacology, Vol. 222, H. 2. S. 293-302.

Hysek, C. M. and Liechti, M. E.. (2012) Effects of MDMA alone and after pretreatement with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex. Psychopharmacology, Vol. 224, no. 3. S. 363-376.

Hysek, C. and Schmid, Y. and Rickli, A. and Simmler, L. D. and Donzelli, M. and Grouzmann, E. and Liechti, M. E.. (2012) Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans. British journal of pharmacology, Vol. 166, H. 8. S. 2277-2288.

2011

Hysek, C. M. and Simmler, L. D. and Ineichen, M. and Grouzmann, E. and Hoener, M. C. and Brenneisen, R. and Huwyler, J. and Liechti, M. E.. (2011) The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA ("Ecstasy") in Humans. Clinical pharmacology and therapeutics, Vol. 90, H. 2. S. 246-255.

Derungs, A. and Schietzel, S. and Meyer, M. R. and Maurer, H. H. and Krahenbuhl, S. and Liechti, M. E.. (2011) Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone). Clinical toxicology, Vol. 49, H. 7. S. 691-3.

Bruggisser, Marcel and Bodmer, Michael and Liechti, Matthias E.. (2011) Severe toxicity due to injected but not oral or nasal abuse of methylphenidate tablets. Swiss medical weekly, Vol. 141 , w13267.

Simmler, L. D. and Hysek, C. M. and Liechti, M. E.. (2011) Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects. Journal of clinical endocrinology and metabolism, Vol. 96, H. 9. S. 2844-2850.

D'Souza, M. S. and Liechti, M. E. and Ramirez-Nino, A. M. and Kuczenski, R. and Markou, A.. (2011) The metabotropic glutamate 2/3 receptor agonist LY379268 blocked nicotine-induced increases in nucleus accumbens shell dopamine only in the presence of a nicotine-associated context in rats. Neuropsychopharmacology, 36 (10). pp. 2111-2124.

2010

Hysek, C. M. and Vollenweider, F. X. and Liechti, M. E.. (2010) Effects of a beta-blocker on the cardiovascular response to MDMA (Ecstasy). Emergency medicine journal, Vol. 27, H. 8. S. 586-589.

Bruggisser, Marcel and Ceschi, Alessandro and Bodmer, Michael and Wilks, Martin F. and Kupferschmidt, Hugo and Liechti, Matthias E.. (2010) Retrospective analysis of stimulant abuse cases reported to the Swiss Toxicological Information Centre during 1997-2009. Swiss medical weekly, Vol. 140 , w13115.

2009

Fiegler, K. and Liechti, M. E. and Bodmer, M. and Bruggisser, M.. (2009) Akzidentelle Lithiumintoxikation = Intoxication with lithium. Schweizerische Rundschau für Medizin Praxis, Jg. 98, Nr. 13. S. 685-691.

Bodmer, M. and Haschke, M. and Bravo, Rätz and Liechti, M. E.. (2009) Nierenversagen und hämolytische Anämie = Acute renal failure due to rifampicine. Schweizerische Rundschau für Medizin Praxis, Jg. 98, Nr. 4. S. 179-185.

2008

Bodmer, M. and Christ, A. and Liechti, M. E.. (2008) Intoxikation mit einem unbekannten Sedativum = Intoxication with an unknown sedative substance. Schweizerische Rundschau für Medizin Praxis, Jg. 97, Nr. 15. S. 820-825.

Liechti, Matthias E. and Markou, Athina. (2008) Role of the glutamatergic system in nicotine dependence : implications for the discovery and development of new pharmacological smoking cessation therapies. CNS drugs, Vol. 22, no. 9. S. 705-724.

Liechti, Matthias E. and Markou, Athina. (2008) Role of the glutamatergic system in nicotine dependence : implications for the discovery and development of new pharmacological smoking cessation therapies. CNS drugs, Vol. 22, H. 9. S. 705-724.